Market	Type	Industry	Raised	Date
AIM	Aquisition / investment	Health	£174.5	Feb 2008

CONTACTS

CEO: Tony Veverka +44 (0) 800 096 2070

ADVISERS

3i
Richard Campin 020-7928 3131	16 Palace Street London SE1E 5JD

COMMENT

Vision correction provider, Ultralase, has recieved £174.5 million of investment from private equity house 3i, who take over control of the firm

Related Articles

• Astbury Marsden's £12.5 million buy-out
• Superglass joins Official List
• Targetti buys Louis Poulsen
• Aurigo adds a new tool to its box
• 3i backs Fabrik’s expansion

People who read this article also read ...

• The smaller the better
• Today's deal headlines
• Growth of law firms 'unsustainable' says Eversheds report
• HMRC extends its net
• Management buys care home operator